Generalized muscle pseudo-hypertrophy and stiffness associated with the myotilin Ser55Phe mutation: a novel myotilinopathy phenotype?

dc.contributor.authorGamez, Josep
dc.contributor.authorArmstrong i Morón, Judith
dc.contributor.authorShatunov, Alexey
dc.contributor.authorSelva O'Callaghan, Albert
dc.contributor.authorDomínguez Oronoz, Rosa
dc.contributor.authorOrtega, Arantxa
dc.contributor.authorGoldfarb, Lev G.
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)
dc.contributor.authorOlivé i Plana, Montserrat
dc.date.accessioned2019-01-21T13:39:22Z
dc.date.available2019-01-21T13:39:22Z
dc.date.issued2009-02-15
dc.date.updated2019-01-21T13:39:22Z
dc.description.abstractMyotilinopathies are a group of muscle disorders caused by mutations in the MYOT gene. It was first described in two families suffering from limb girdle muscle dystrophy type 1 (LGMD 1A), and later identified in a subset of dominant or sporadic patients suffering from myofibrillar myopathy, as well as in a family with spheroid body myopathy. Disease phenotypes associated with MYOT mutations are clinically heterogeneous and include pure LGMD forms as well as late-onset distal myopathies. We report here on a 53-year-old male suffering from a unique clinical profile characterized by generalized symmetrical increase in muscle bulk leading to a Herculean appearance. Muscle weakness and stiffness in the lower extremities were the patient's main complaints. Muscle MRI showed extensive fatty infiltration in the thigh and leg muscles and a muscle biopsy showed a myofibrillar myopathy with prominent protein aggregates. Gene sequencing revealed a Ser55Phe missense mutation in the myotilin gene. The mutation was identified in his older brother, who presented a mild hypertrophic appearance and had a myopathic pattern in EMG, despite not presenting any of the complaints of the proband and having normal muscle strength. This finding, and his deceased father and paternal aunt's similar gait disorders, suggest that this is in fact a new autosomal dominant kindred. The present observations further expand the spectrum of clinical manifestations associated with mutations in the myotilin gene.
dc.format.extent5 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec600993
dc.identifier.issn0022-510X
dc.identifier.pmid19027924
dc.identifier.urihttps://hdl.handle.net/2445/127475
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.jns.2008.10.019
dc.relation.ispartofJournal of the Neurological Sciences, 2009, vol. 277, num. 1-2, p. 167-171
dc.relation.urihttps://doi.org/10.1016/j.jns.2008.10.019
dc.rights(c) Elsevier B.V., 2009
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationFenotip
dc.subject.classificationMalalties musculars
dc.subject.classificationHipertròfia
dc.subject.classificationExpressió gènica
dc.subject.otherPhenotype
dc.subject.otherMuscular Diseases
dc.subject.otherHypertrophy
dc.subject.otherGene expression
dc.titleGeneralized muscle pseudo-hypertrophy and stiffness associated with the myotilin Ser55Phe mutation: a novel myotilinopathy phenotype?
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
600993.pdf
Mida:
2 MB
Format:
Adobe Portable Document Format